Cardio Diagnostics Holdings - CDIO Company Value to Revenue Ratio

Official company branding of Cardio Diagnostics Holdings Inc. (CDIO)

After evaluating the EV/Sales multiple on GURU.Markets, we find that the figure is 65000.00. Cardio Diagnostics (CDIO) is scaling its IT platform through telemedicine partnerships. Patents for the genetic analysis of cardiac pathologies protect its niche from large laboratory networks. Epigenetic tests are being implemented in collaboration with primary care clinics for the effective prevention of vascular diseases.

CDIO Cardio Diagnostics Holdings, Inc.: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/19/2026

Cardio Diagnostics Holdings Inc. - analytical breakdowns and key metrics (CDIO)

Fundamental company valuation:CDIO (Cardio Diagnostics Holdings Inc.)
Product sample of Cardio Diagnostics Holdings

This multiple determines the total enterprise value, including debt and minus cash, per unit of sales, allowing for an assessment of asset monetization efficiency regardless of financial leverage. The price action of the EV/Sales ratio reflects market expectations for the scaling of the Cardio Diagnostics (CDIO) AI platform, where a high valuation is justified by the network effect of data and high customer switching costs.

Competitor analysis for Cardio Diagnostics

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Sales Ratio Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - EV/Sales Multiple|Cytek Biosciences (CTKB) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple OSUR|Exagen - Company Value to Revenue Ratio|EV/Sales Multiple MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Enterprise Value-to-Revenue Multiple|prenetics.com - EV/Sales Multiple|Insight Molecular Diagnostics, Inc. (IMDX) - Company Value to Revenue|TRIB: EV/Sales Multiple|ProPhase - Business Value to Revenue|Enterprise Value-to-Revenue Ratio ainos.com|CODX: Business Value to Revenue|Enterprise Value-to-Revenue Ratio HeartSciences (HSCS)|Company Value to Revenue Biomerica Inc. BMRA|EV/Sales Multiple ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue